Effect of HEMADO on level of CK-MB and LDH enzymes after ischemia/reperfusion injury in isolated rat heart

BioImpacts

Volumn 3, Issue 2, 2013, Pages 101-104

  Amani, Mohammad ^a   Jeddi, Sajad ^b,c   Ahmadiasl, Nasser ^c   Usefzade, Nasibe ^c   Zaman, Jalal ^b  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Creatine; Dehydrogenase; HEMADO; Injury mitoKATP; Ischemia Reperfusion; Kinase; Lactate

Indexed keywords

2 (1 HEXYNYL) N METHYLADENOSINE; 5 HYDROXYDECANOIC ACID; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CREATINE KINASE MB; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME RELEASE; HEART MUSCLE; HEART PROTECTION; MALE; NONHUMAN; PRESSURE; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TEMPERATURE; UREA CYCLE;

EID: 84881513604     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2013.003     Document Type: Article

References (34)

1. Yin X, Zheng Y, Zhai X, Zhao X, Cai L. Diabetic inhibition of preconditioning-and postconditioning-mediated myocardial protection against ischemia/reperfusion injury. Exp Diabetes Res 2012:198048.
2. Liem DA, Honda HM, Zhang J, Woo D, Ping P. Past and present course of cardioprotection against ischemia-reperfusion injury. J Appl Physiol 2007;103:2129-36.
3. Cohen J. The Global Burden of Disease Study: A useful projection of future global health? J Public Health Med 2000;22:518-24.
4. Vinten-Johansen J, Zhao ZQ, Jiang R, Zatta AJ, Dobson GP. Preconditioning and postconditioning: Innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol 2007;103:1441-8.
5. Braunwald E, Kloner RA. Myocardial reperfusion: A double-edged sword? J Clin Invest 1985;76:1713-9.
6. Vinten-Johansen J, Johnston WE, Mills SA, Faust KB, Geisinger KR, DeMasi RJ, et al. Reperfusion injury after temporary coronary occlusion. J Thorac Cardiovasc Surg 1988;95:960-8.
7. Tonkovic-Capin M, Gross GJ, Bosnjak ZJ, Tweddell JS, Fitzpatrick CM, Baker JE. Delayed cardioprotection by isoflurane: Role of K(ATP) channels. Am J Physiol Heart Circ Physiol 2002;283:H61-8.
8. Headrick JP, Lasley RD. Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol 2009;193:189-214.
9. Liang BT, Jacobson KA. A physiological role of the adenosine A3 receptor: Sustained cardioprotection. Proc Natl Acad Sci U S A 1998;95:6995-9.
10. Borea PA, Gessi S, Bar-Yehuda S, Fishman P. A3 adenosine receptor: Pharmacology and role in disease. Handb Exp Pharmacol 2009;193:297-327.
11. Rajesh KG, Sasaguri S, Suzuki R, Xing Y, Maeda H. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels. Int J Cardiol 2004;96:41-9.
12. Tsukamoto O, Asanuma H, Kim J, Minamino T, Takashima S, Ogai A, et al. A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart. Biochem Biophys Res Commun 2005;338:1460-6.
13. Ge ZD, Peart JN, Kreckler LM, Wan TC, Jacobson MA, Gross GJ, et al. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-Nmethylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther 2006;319:1200-10.
14. Downey JM, Cohen MV. Free radicals in the heart: Friend or foe? Expert Rev Cardiovasc Ther 2008;6:589-91.
15. Rossoni G, Manfredi B, Civelli M, Berti F, Razzetti R. Combined simvastatin-manidipine protect against ischemia-reperfusion injury in isolated hearts from normocholesterolemic rats. Eur J Pharmacol 2008;587:224-30.
16. Wan TC, Ge ZD, Tampo A, Mio Y, Bienengraeber MW, Tracey WR, et al. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J Pharmacol Exp Ther 2008;324:234-43.
17. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005;100:179-90.
18. Ko SH, Yu CW, Lee SK, Choe H, Chung MJ, Kwak YG, et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analy 1997;85:719-24.
19. Budas GR, Jovanovic S, Crawford RM, Jovanovic A. Hypoxia-induced preconditioning in adult stimulated cardiomyocytes is mediated by the opening and trafficking of sarcolemmal KATP channels. FASEB J 2004;18:1046-8.
20. Baghelai K, Graham LJ, Wechsler AS, Jakoi ER. Delayed myocardial preconditioning by alpha1-adrenoceptors involves inhibition of apoptosis. J Thorac Cardiovasc Surg 1999;117:980-6.
21. Sukhodub A, Jovanovic S, Du Q, Budas G, Clelland AK, Shen M, et al. AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels. J Cell Physiol 2007;210:224-36.
22. Hanley PJ, Drose S, Brandt U, Lareau RA, Banerjee AL, Srivastava DK, et al. 5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids. J Physiol 2005;562:307-18.
23. Garlid KD, Dos Santos P, Xie ZJ, Costa AD, Paucek P. Mitochondrial potassium transport: The role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim Biophys Acta 2003;1606:1-21.
24. Guillet V, Gueguen N, Cartoni R, Chevrollier A, Desquiret V, Angebault C, et al. Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation. FASEB J 2011;25:1618-27.
25. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 2001;89:273-8.
26. Notsu T, Ohhashi K, Tanaka I, Ishikawa H, Niho T, Fukutake K, et al. 5-Hydroxydecanoate inhibits ATP-sensitive K+ channel currents in guinea-pig single ventricular myocytes. Eur J Pharmacol 1992;220:35-41.
27. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 2003;60:617-25.
28. Petrosillo G, Di Venosa N, Moro N, Colantuono G, Paradies V, Tiravanti E, et al. In vivo hyperoxic preconditioning protects against ratheart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Free Radic Biol Med 2010;50:477-83.
29. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 2012;149:1536-48.
30. Nicoud IB, Knox CD, Jones CM, Anderson CD, Pierce JM, Belous AE, et al. 2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptake. Am J Physiol Gastrointest Liver Physiol 2007;293:G623-30.
31. Rossoni G, Manfredi B, De Gennaro Colonna V, Brini AT, Polvani G, Clement MG, et al. Nitric oxide and prostacyclin pathways: An integrated mechanism that limits myocardial infarction progression in anaesthetized rats. Pharmacol Res 2006;53:359-66.
32. Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA. Calcium in cell injury and death. Annu Rev Pathol 2006;1:405-34.
33. Zhu HL, Wei X, Qu SL, Zhang C, Zuo XX, Feng YS, et al. Ischemic postconditioning protects cardiomyocytes against ischemia/reperfusion injury by inducing MIP2. Exp Mol Med 2011;43:437-45.
34. Costa AD, Garlid KD. MitoKATP activity in healthy and ischemic hearts. J Bioenerg Biomembr 2009;41:123-6.